Brilinta 90mg Tablets | 100-Count | TICAGRELOR
🇮🇳 India Warehouse
TICAGRELOR — 90mg per tablet, 100-count pack.
P2Y12 antiplatelet agent for acute coronary syndrome (ACS) and post-MI prevention. Faster, more potent, more consistent platelet inhibition than clopidogrel — reduces mortality after heart attack.
* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.
{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is Brilinta 90mg (1X180) used for?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”P2Y12 antiplatelet agent for acute coronary syndrome (ACS) and post-MI prevention. Faster, more potent, more consistent platelet inhibition than clopidogrel — reduces mortality after heart attack.”}},{“@type”:”Question”,”name”:”What are the side effects of TICAGRELOR?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Dyspnea (unique to ticagrelor — usually mild, not cardiac), bleeding, bradyarrhythmia (transient), elevated uric acid.”}},{“@type”:”Question”,”name”:”Where does this ship from?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Ships from India Warehouse — international delivery worldwide.”}}]}
What is Brilinta 90mg (1X180) (TICAGRELOR)?
P2Y12 antiplatelet agent for acute coronary syndrome (ACS) and post-MI prevention. Faster, more potent, more consistent platelet inhibition than clopidogrel — reduces mortality after heart attack.
How it Works
Direct-acting reversible P2Y12 ADP receptor antagonist — no metabolic activation required unlike clopidogrel. More predictable and potent antiplatelet effect.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | TICAGRELOR |
| Dose per Tablet | 90MG |
| Pack Size | 10×10 (100 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Dyspnea (unique to ticagrelor — usually mild, not cardiac), bleeding, bradyarrhythmia (transient), elevated uric acid.
Safety Warnings
⚠️ Dyspnea: evaluate for cardiac/pulmonary causes but may be drug effect (usually resolves). Avoid strong CYP3A4 inhibitors/inducers. High bleeding risk especially GI. Do NOT use high-dose aspirin with ticagrelor.
Frequently asked questions
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
Reviews
Clear filtersThere are no reviews yet.